1-4 of 4
r-cvp regimen
Close
Sort by
Journal Articles

R-CVP Chemoimmunotherapy for Limited-Stage Ocular Adnexal MALT Lymphoma with Adverse Factors: A Phase II Study

Sung-Yong Kim, MD, Seok-Goo Cho, Won-Sik Lee, MD, Suk-Woo Yang, MD, Sung Yong Oh, MD, Hee Bae Ahn, MD, Deok-Hwan Yang, Seong Kyu Park, Jee Ho Chang, MD, Hyo Jung Kim, MD PhD, Min Joung Lee, Jae Wook Yang
Journal: Blood
Blood (2016) 128 (22): 2981.
https://doi.org/10.1182/blood.V128.22.2981.2981
Published: 2016
Journal Articles

An Open-Label, Phase I Study of R-CVP in Combination with Inotuzumab Ozogamicin in Patients with Relapsed/Refractory CD22-Positive B-Cell Non-Hodgkin Lymphoma,

Michinori Ogura, Toshiki Uchida, David A MacDonald, Kiyohiko Hatake, Andrew Davies, Randeep Sangha, Michael Crump, MD, FRCPC, Catherine Thieblemont, MD, Taro Ishibashi, Steven Hua, Luisa Paccagnella, Erik R Vandendries, MD, PhD, Yukio Kobayashi, Kensei Tobinai, MD
Journal: Blood
Blood (2011) 118 (21): 3715.
https://doi.org/10.1182/blood.V118.21.3715.3715
Published: 2011
Journal Articles

Chlorambucil Induced Angioedema of the Tongue in a Patient with Lymphoma.

A. Majid Shojania, MD
Journal: Blood
Blood (2006) 108 (11): 4618.
https://doi.org/10.1182/blood.V108.11.4618.4618
Published: 2006
Journal Articles

Rituximab-CHOP Significantly Improve the Response of Advanced Extranodal Marginal Zone B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue (MALT Lymphoma).

Daisuke Ennishi, MD, Yasuhito Terui, MD,PhD, Tomohiro Myojo, MD, Yuko Mishima, MD, Masahiro Yokoyama, MD, Shunji Takahashi, MD,PhD, Kengo Takeuchi, MD,PhD, Kiyohiko Hatake, MD,PhD
Journal: Blood
Blood (2006) 108 (11): 4715.
https://doi.org/10.1182/blood.V108.11.4715.4715
Published: 2006